In Situ Hybridization Market worth $3.10 billion by 2030, growing at a CAGR of 7.92% - Exclusive Report by 360iResearch

The "In Situ Hybridization Market by Product (Consumables, Instruments, Software), Technology (Chromogenic In Situ Hybridization, Fluorescence In Situ Hybridization), Application, End User - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.

The Global In Situ Hybridization Market to grow from USD 1.81 billion in 2023 to USD 3.10 billion by 2030, at a CAGR of 7.92%.

Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/in-situ-hybridization?utm_source=openpr&utm_medium=referral&utm_campaign=sample

In-situ hybridization is a process utilized to identify and detect specific DNA sequences in cells with an increasing number of unknown viruses. In-situ hybridization allows precise localization of a specific nucleic acid segment within a histologic section. It is a major laboratory technique used to localize an RNA or DNA sequence in a biological sample. The prevalence of chronic diseases and the need for rapid diagnostic techniques contribute to the increasing adoption of in-situ hybridization. Cancer was among the leading cause of death in 2020, with approximately 100 million deaths worldwide. Growing demand for molecular diagnostic tools and advancements in the field of IVD is anticipated to boost the adoption of in-situ hybridization (ISH) technology in the coming years. High costs and limited skilled professionals for managing in-situ hybridization hamper the adoption of in-situ hybridization. However, the ongoing technological advancements and increasing research and development (R&D) to introduce innovative in-situ hybridizations are expected to create opportunities for the growth of the in-situ hybridization market.

The presence of technologically upgraded infrastructure in the U.S., Canada, and Brazil is increasing the adoption of ISH, which enables early diagnosis of diseases. Furthermore, key players in the In Situ Hybridization (ISH) market and the launch of innovative products in the region are expected to fuel the In Situ Hybridization (ISH) industry growth in the Americas. In December 2022, OmicsVeu launched an extensive line of spatial biology products, mRNA and DNA FISH probes, and kits. A wide range of over 220 plus fluorophore-tagged miRNA probes enables the generation of multiplex miRNA profiling. Increasing investments in R&D pertaining to IVD in Europe driving the adoption of in situ hybridization (ISH) market. The presence of government organizations in the region, including the European Diagnostic Manufacturers Association (EDMA), which focuses on the development and overall growth of the European IVD industry, is contributing to the growth of the ISH market in Europe.

Market Segmentation & Coverage:

This research report categorizes the In Situ Hybridization Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Consumables, Instruments, and Software. The Consumables is further studied across Accessories, Kits & Reagents, and Probes. The Instruments is projected to witness significant market share during forecast period.

Based on Technology, market is studied across Chromogenic In Situ Hybridization and Fluorescence In Situ Hybridization. The Fluorescence In Situ Hybridization is further studied across DNA Fluorescence In Situ Hybridization, PNA Fluorescence In Situ Hybridization, and RNA Fluorescence In Situ Hybridization. The Chromogenic In Situ Hybridization is projected to witness significant market share during forecast period.

Based on Application, market is studied across Cancer Diagnostics, Cytology, Immunology, Infectious Disease Diagnostics, and Neuroscience. The Cytology is projected to witness significant market share during forecast period.

Based on End User, market is studied across Academic & Research Institutes, Contract Research Organizations, Hospital & Diagnostic Laboratories, and Pharmaceutical & Biotechnology Companies. The Academic & Research Institutes is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.

Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/in-situ-hybridization?utm_source=openpr&utm_medium=referral&utm_campaign=inquire

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the In Situ Hybridization Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in the In Situ Hybridization Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Key Company Profiles:

The report delves into recent significant developments in the In Situ Hybridization Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam Plc, Abnova Corporation, Advanced Cell Diagnostics, Inc., Agilent Technologies, Inc., Bio SB, Bio-Rad Laboratories, Inc., Biocare Medical, LLC, BioCat GmbH, Bioevopeak Co., Ltd. |, BioGenex Laboratories, Biomers.net GmbH, BioView Ltd., Cell Line Genetics, Inc., CellCarta Biosciences Inc., Charles River Laboratories International, Inc., CiteAb Ltd., Cole-Parmer Instrument Company, LLC., Creative Bioarray, Creative Biolabs, Daicel Arbor Biosciences, DSS Imagetech Pvt. Ltd., Emsurg Healthcare (India) Pvt. Limited, Enzo Life Sciences, Inc., Excilone, F. Hoffmann-La Roche Ltd, Flogentec, GeneDetect.com Limited, Intertek Group PLC, KromaTiD Inc., Leica Biosystems Nussloch GmbH, Merck KGaA, Molecular Instruments, Inc., NeoGenomics Laboratories, Inc., Okabé Bureau, Opgen, Oxford Gene Technology IP Limited, PerkinElmer Inc., Qiagen N.V., QIMA Life Sciences, Reveal Biosciences, Inc., Ribocon GmbH, Spatial Genomics, Inc., Stratech Scientific Ltd, Suraksha Diagnostic Private Limited, Thermo Fisher Scientific Inc., Vector Laboratories, Inc., Zytomed Systems GmbH, and ZytoVision GmbH.

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. In Situ Hybridization Market, by Product
7. In Situ Hybridization Market, by Technology
8. In Situ Hybridization Market, by Application
9. In Situ Hybridization Market, by End User
10. Americas In Situ Hybridization Market
11. Asia-Pacific In Situ Hybridization Market
12. Europe, Middle East & Africa In Situ Hybridization Market
13. Competitive Landscape
14. Competitive Portfolio

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the In Situ Hybridization Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the In Situ Hybridization Market?
3. What is the competitive strategic window for opportunities in the In Situ Hybridization Market?
4. What are the technology trends and regulatory frameworks in the In Situ Hybridization Market?
5. What is the market share of the leading vendors in the In Situ Hybridization Market?
6. What modes and strategic moves are considered suitable for entering the In Situ Hybridization Market?

Read More @ https://www.360iresearch.com/library/intelligence/in-situ-hybridization?utm_source=openpr&utm_medium=referral&utm_campaign=analyst

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.